ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36558166

Extraction of Naringin from Pomelo and Its Therapeutic Potentials against Hyperlipidemia.

Yu X and 4 others. Molecules, 2022. Cited by 21 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Extraction of Naringin from Pomelo and Its Therapeutic Potentials against Hyperlipidemia. Papers, record 36558166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36558166

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extraction of Naringin from Pomelo and Its Therapeutic Potentials against Hyperlipidemia.
PubMed
Journal
Molecules
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu XXiaoleihttps://orcid.org/0000-0003-3801-3512
2Meng XXin
3Yan YYidi
4Wang HHui
5Zhang LLeihttps://orcid.org/0000-0002-4880-824X

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HyperlipidemiasMajor topic
Mice
Animals
Cattle
Cholesterol, LDL
Lipids
Liver
Diet, High-Fat
Superoxide Dismutase
Triglycerides
Flavanones

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,962,080A new multifunctional hydroxytyrosol-fenofibrate with antidiabetic, antihyperlipidemic, antioxidant and antiinflammatory action.Biomed Pharmacother2017https://conductscience.org/library/papers/28962080PubMed
231,901,198Protective Effects of Naringin in Cerebral Infarction and Its Molecular Mechanism.Med Sci Monit2020https://conductscience.org/library/papers/31901198PubMed
322,609,541FXR signaling in the enterohepatic system.Mol Cell Endocrinol2013https://conductscience.org/library/papers/22609541PubMed
417,426,312High-fat diets: modeling the metabolic disorders of human obesity in rodents.Obesity (Silver Spring)2007https://conductscience.org/library/papers/17426312PubMed
529,080,465Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats.Biomed Pharmacother2018https://conductscience.org/library/papers/29080465PubMed
623,500,445A newly identified polysaccharide from Ganoderma atrum attenuates hyperglycemia and hyperlipidemia.Int J Biol Macromol2013https://conductscience.org/library/papers/23500445PubMed
731,727,500Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway.Pathol Res Pract2019https://conductscience.org/library/papers/31727500PubMed
823,196,156Antidiabetic plants and their active constituents.Phytomedicine1995https://conductscience.org/library/papers/23196156PubMed
912,440,980Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.Biochem Soc Trans2002https://conductscience.org/library/papers/12440980PubMed
1023,871,784Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats.Food Chem Toxicol2013https://conductscience.org/library/papers/23871784PubMed

1 to 10 of 20

See all 20 references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42,789,955Pharmacological potential of pomelo (Citrus maxima) peel: A bibliometric review of global research trends and future directions.J Food Drug Anal2026https://conductscience.org/library/papers/42789955PubMed
41,984,274New Advances in the Mechanisms and Therapeutic Strategies of Gut Microbiota in Regulating Glycolipid Metabolism to Combat Atherosclerosis.J Cardiovasc Transl Res2026https://conductscience.org/library/papers/41984274PubMed
41,229,959Development and optimization of green extraction of naringin in Citrus grandis 'Tomentosa' using natural deep eutectic solvents (NADES) and investigation of lung cancer therapeutics mechanisms.RSC Adv2025https://conductscience.org/library/papers/41229959PubMed
41,170,356Natural compounds regulating fatty acid oxidation in the treatment of diabetic kidney disease.Front Nutr2025https://conductscience.org/library/papers/41170356PubMed
40,628,764Investigating the anti-hypolipidemic effects of croissants enriched with fruit byproducts in a rat model.NPJ Sci Food2025https://conductscience.org/library/papers/40628764PubMed
40,520,525Naringin ameliorates high-fat diet-induced hepatotoxicity and dyslipidemia in experimental rat model via modulation of anti-oxidant enzymes, AMPK and SERBP-1c signaling pathways.Toxicol Rep2025https://conductscience.org/library/papers/40520525PubMed
40,098,613Bioactive flavonoids metabolites in citrus species: their potential health benefits and medical potentials.Front Pharmacol2025https://conductscience.org/library/papers/40098613PubMed
39,683,934Optimization of Naringin Extraction, Synthesis of Dihydrochalcone and Its Effects on Reducing Blood Lipid Levels In Vitro.Molecules2024https://conductscience.org/library/papers/39683934PubMed
39,596,162A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.Int J Mol Sci2024https://conductscience.org/library/papers/39596162PubMed
39,474,612Naringenin modulates oxidative stress and lipid metabolism: Insights from network pharmacology, mendelian randomization, and molecular docking.Front Pharmacol2024https://conductscience.org/library/papers/39474612PubMed

1 to 10 of 18

See all 18 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
SLC17A526,503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36558166

GET https://conductscience.org/api/papers/v1/36558166/authors

API referenceFor AI assistants